A study of children with chronic GVHD showed that none reported having positive experiences at school. Researchers evaluated oral suspensions because patients with certain types of GVHD may have difficulty swallowing a tablet. Researchers surveyed nurses at centers with a high volume of allogeneic HSCT. Oncology nurses have a central role in glycemia control, beginning with a clear assessment of glucose blood levels. To manage aGVHD, oncology nurses often give high-dose glucocorticoids that can cause steroid-induced hyperglycemia. The GI tract, commonly called “the gut,” is a frequent target of GVHD, in particular aGVHD. Dealing with the long-term, life-altering, uncomfortable symptoms of chronic GVHD can be difficult to accept. Mary Mansour Riwes, DO, explains what she saw as the important news in GVHD at the 2024 Tandem Meetings. Mary Mansour Riwes, DO, speaks about research on the topic that she presented at the 2024 Tandem Meetings. High-dose PTCy is the “standard of care" for certain patients but the “optimal dosing of PTCy has not been defined." The 3-year follow-up analysis included 152 patients with cGVHD who received 2-5 prior lines of systemic therapy. Stephanie J. Lee, MD, MPH, speaks about what she sees as the key GVHD highlights at the Tandem Meetings. Contrast-enhanced ultrasonography is a noninvasive method that "could contribute to GVHD diagnosis and management guidance." The study showed a certain type of aGVHD is the predominant form that occurs after PTCy-based prophylaxis. The randomized, double-blind trial evaluated the efficacy and safety of ruxolitinib 1.5% cream. The current diagnostic criteria for CNS GVHD “does not cover a majority of cases with strong clinical suspicion." Dr. Lee speaks about study evaluating belumosudil in cGVHD and highlights the critical role of nurses in GVHD care. The phase III BMT CTN 1301 trial evaluated CNI-free strategies using T-cell depletion without additional immune suppression. A team implemented a database that obtained “near real-time” information on GVHD-related telehealth visits. The combination was “exceptionally potent in diminishing” aGVHD, but there was 1 risk factor for developing aGVHD.